Columbia University

Technology Ventures

Biopharma Perspectives on Early Venture Investing and R&D

On February 11, 2016, CTV hosted a lively panel discussion with Marian Nakada (Johnson & Johnson Innovation – JJDC), Bob Silverman (Roche) and Steven Weinstein (Novartis Ventures), moderated by CTV’s executive director Orin Herskowitz. The conversation covered the various ways Big Pharma & Biotech are using venture capital investing, regional innovation centers, joint ventures, university research sponsorship, and IP licensing to source their next blockbuster products (as well as generate equity returns).

Co-sponsored by Columbia Engineering, the Eugene Lang Center for Entrepreneurship, Columbia Entrepreneurship, and the Healthcare and Pharmaceutical Management Program at Columbia Business School.